Islet-intrinsic effects of CFTR mutation

Area of Science:

• Endocrinology
• Genetics
• Pulmonology

Background:

• Cystic fibrosis-related diabetes (CFRD) is a major complication in cystic fibrosis (CF) patients, accelerating lung disease.
• Traditionally, CFRD was attributed to pancreatic fibrosis, but emerging evidence points to a role for the cystic fibrosis transmembrane-conductance regulator (CFTR) in pancreatic islet function.

Purpose of the Study:

• To review emerging evidence supporting a primary role of endocrine pancreatic dysfunction in CFRD development.
• To explore the implications of CFTR's role in beta cells for CFRD pathogenesis and treatment.

Main Methods:

• Review of recent experimental evidence on CFTR function in pancreatic beta cells.
• Analysis of studies showing differences in endocrine pancreatic morphology in CF patients.
• Examination of impaired insulin secretion and glucose homeostasis in CF.

Main Results:

• CFTR expression is confirmed in human and mouse beta cells.
• Functional CFTR channels are essential for insulin exocytosis and beta cell membrane potential regulation.
• Impaired first-phase insulin responses and glucose homeostasis are observed in CF patients.

Conclusions:

• CFRD pathogenesis is more complex than previously thought, involving primary endocrine pancreatic dysfunction.
• Novel insights into CFTR's role in beta cells suggest personalized treatment approaches for CFRD.
• CFTR corrector and potentiator drugs may offer new therapeutic avenues for CFRD.